Quest Diagnostics Inc logo

DGX - Quest Diagnostics Inc News Story

$125.21 0.7  0.6%

Last Trade - 07/08/20

Sector
Healthcare
Size
Large Cap
Market Cap £12.88bn
Enterprise Value £15.73bn
Revenue £5.77bn
Position in Universe 525th / 6395

Quest Diagnostics COVID-19 test kit gets FDA nod for emergency use

Thu 28th May, 2020 6:26pm
May 28 (Reuters) - Quest Diagnostics  DGX.N  on Thursday
received emergency use authorization from the U.S. Food and Drug
Administration for its self-collection COVID-19 test kit. 
    The test allows people to swab the front part of the nostril
at home or in a healthcare setting when deemed necessary.
 urn:newsml:reuters.com:*:nPn4Z2WJga

 (Reporting by Trisha Roy in Bengaluru; Editing by Amy Caren
Daniel)
 ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3635;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.